Export 5 results:
Author [ Title(Desc)] Type Year
Filters: Author is Farrant, Mary  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
M. Farrant, J Easton, D., Adelman, E. E., Cucchiara, B. L., Barsan, W. G., Tillman, H. J., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zhao, W., Pauls, K., Walsh, K. B., Martí-Fàbregas, J., Bernstein, R. A., and S Johnston, C., “Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.”, JAMA Netw Open, vol. 2, no. 9, p. e1910769, 2019.
P
C. S Johnston, J Easton, D., Farrant, M., Barsan, W., Battenhouse, H., Conwit, R., Dillon, C., Elm, J., Lindblad, A., Morgenstern, L., Poisson, S. N., and Palesch, Y., “Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.”, Int J Stroke, vol. 8, no. 6, pp. 479-83, 2013.
R
H. Tillman, S Johnston, C., Farrant, M., Barsan, W., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., and J Easton, D., “Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.”, JAMA Neurol, vol. 76, no. 7, pp. 774-782, 2019.
S
J. J. Elm, Palesch, Y., J Easton, D., Lindblad, A., Barsan, W., Silbergleit, R., Conwit, R., Dillon, C., Farrant, M., Battenhouse, H., Perlmutter, A., and S Johnston, C., “Screen failure data in clinical trials: Are screening logs worth it?”, Clin Trials, vol. 11, no. 4, pp. 467-472, 2014.
T
C. S Johnston, Elm, J. J., J Easton, D., Farrant, M., Barsan, W. G., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zurita, K. G., Albers, G. W., Cucchiara, B. L., Kleindorfer, D. O., Lutsep, H. L., Pearson, C., Sethi, P., and Vora, N., “Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.”, Circulation, vol. 140, no. 8, pp. 658-664, 2019.